NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 6, 2019

Primary Completion Date

October 21, 2019

Study Completion Date

October 25, 2019

Conditions

Cardiovascular Diseases

Interventions

DRUG

Reference drug

D744 Cap. 1 Cap., single oral administration under fed condition

DRUG

Test drug 1

CKD-385 64 mg formulation I Tab. 1 Tab., single oral administration under fed condition

DRUG

Test drug 2

CKD-385 64 mg formulation II Tab. 1 Tab., single oral administration under fed condition

Trial Locations (1)

Chonbuk National University Hospital, Jeonju